https://www.yaozhi.cloud 2026-09-28 webpage 药智云 - 医药营销执行记录与合规支持 | 事后可追溯 · 清晰可复盘 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/about.html 2026-09-28 webpage 关于我们 - 药智云 | 专注医药营销执行记录与合规支持 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/about/yaozhiyun-vs-yaozhiwang.html 2026-09-21 webpage 药智云和药智网是一家吗？品牌区分说明 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/ai-knowledge.html 2026-09-21 webpage 药智云品牌说明 - 杭州药智云科技有限公司 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/careers.html 2026-09-28 webpage 加入我们 - 药智云招聘 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/cases.html 2026-09-28 webpage 客户案例 - 药智云 | 执行记录与合规支持实践 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/contact.html 2026-09-29 webpage 联系我们 - 药智云 | 预约产品演示 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/ 2026-09-30 knowledge 知识中心 - 药智云医药数智化知识库 | 行业洞察与解决方案指南 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/2026-terminal-management.html 2026-09-28 knowledge 处方药外流院外市场运营指南 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/academic-promotion-digital-transformation.html 2026-09-28 knowledge 学术推广数智化转型 - 从传统会议到全渠道触达 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/beyond-sales-see-flow-stock-sellout.html 2026-09-28 knowledge 看销量不够，为什么还要看流向、库存和终端动销 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/channel-fleeing-goods-tracing.html 2026-09-28 knowledge 渠道窜货追溯：流向数据如何成为取证利器 | 药智云知识中心 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/chronic-disease-digital-adherence.html 2026-09-28 knowledge 慢病管理数智化：如何用数据提升患者依从性 | 药智云知识中心 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/compliance-evidence-chain-shift-left.html 2026-09-28 knowledge 高标准药企合规管理：为什么要把学术活动证据链前移 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/drug-flow-channel-strategy.html 2026-09-28 knowledge 药企如何用流向数据做精准渠道策略 | 药智云知识中心 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/drug-flow-data-analysis-guide.html 2026-09-28 knowledge 药品流向数据分析完全指南 - 从数据采集到业务洞察 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/drug-flow-data-cleaning-pitfalls.html 2026-09-28 knowledge 流向数据清洗的5种常见坑与避坑方法 | 药智云知识中心 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/drug-flow-data-governance-launch-checklist.html 2026-09-29 knowledge 药企流向数据治理上线前检查清单：从数据来源到验收口径 | 药智云知识中心 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/flow-data-first-step-unify-rules.html 2026-09-28 knowledge 流向数据建设的第一步，不是上系统，而是统一口径 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/flow-data-rebate-settlement.html 2026-09-28 knowledge 从流向采集到返利结算，药企真正缺的不是人，是闭环系统 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/flow-data-usable-foundation.html 2026-09-28 knowledge 流向数据不是越多越好，关键是能不能变成可用底座 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/flow-system-not-just-report-layer.html 2026-09-28 knowledge 流向系统为什么不能只停留在报表层 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/flow-system-rebuild-special.html 2026-09-28 knowledge 流向系统重建专题：库存预警、返利结算与经营决策底座｜药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/golden-tax-iv-pharma-impact.html 2026-09-28 knowledge 金税四期对药企营销费用管理的影响与应对 | 药智云知识中心 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/innovation-drug-rws-patient-management.html 2026-09-28 knowledge 创新药临床研究数智化：RWS 与患者管理为什么要前置布局 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/kol-speaker-management-guide.html 2026-09-28 knowledge KOL讲者管理全流程：从签约到费用结算 | 药智云知识中心 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/liuxiang-application-layer-sfe-rebate-analysis.html 2026-09-28 knowledge 流向系统真正值钱的，不是采集，是应用｜药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/meeting-budget-compliance-efficiency.html 2026-09-28 knowledge 学术会议预算管控：如何在合规前提下提升费效比 | 药智云知识中心 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/meeting-compliance-ai-review-intro.html 2026-09-28 knowledge 飞检常态化下学术会议合规检查指南 - AI智能审查系统 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/meeting-compliance-ai-tech-deep-dive.html 2026-09-28 knowledge AI合规技术深度解析：ELA图像取证、向量搜索、多模态识别 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/meeting-compliance-case-studies.html 2026-09-28 knowledge 飞检合规惨案分析：4个典型违规案例与技术解密 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/meeting-compliance-cfo-letter.html 2026-09-28 knowledge 药企学术会议费用管控指南 - CFO视角的三道防线 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/meeting-compliance-cost-reduction.html 2026-09-28 knowledge 药企合规成本降低80%的AI解决方案 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/meeting-compliance-flexible-rules.html 2026-09-28 knowledge 灵活可配置的合规规则引擎设计 - 告别僵化系统 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/mms-four-evidence-compliance-chain.html 2026-09-28 knowledge 药企学术会议「四证」合规证据链：从邀请到评价的闭环管理 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/mms-meeting-lifecycle-digital-management.html 2026-09-28 knowledge 从Excel到数智化平台：药企学术会议全生命周期管理进化之路 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/mms-tri-terminal-collaboration.html 2026-09-28 knowledge 三端协同如何破解药企学术会议管理困局？MMS系统深度解读 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/multi-source-drug-flow-data-integration.html 2026-09-28 knowledge 多源流向数据融合实战：数千家商业公司数据如何归一 | 药智云知识中心 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/otc-terminal-coverage-methodology.html 2026-09-28 knowledge OTC终端覆盖率提升方法论：不只是「多跑几家」 | 药智云知识中心 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/patient-lifecycle-management-guide.html 2026-09-28 knowledge 患者全生命周期管理指南：从首诊到长期随访 | 药智云知识中心 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/pharma-agent-tiered-management-guide.html 2026-09-28 knowledge 医药代理商分级管理实战指南：从粗放招商到精细化渠道运营 | 药智云知识中心 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/pharma-ai-application-landscape.html 2026-09-28 knowledge 医药行业AI应用全景图：从研发到营销的智能化实践 | 药智云知识中心 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/pharma-commercialization-closed-loop.html 2026-09-28 knowledge 药企商业化闭环：从客户增长到终端执行的一体化协同路径 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/pharma-compliance-checklist-2026.html 2026-09-28 knowledge 医药反腐新规下的合规自查清单（2026版） | 药智云知识中心 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/pharma-compliance-management-best-practices.html 2026-09-28 knowledge 医药合规管理最佳实践 - 构建全流程合规体系 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/pharma-digital-transformation-5-stages.html 2026-09-28 knowledge 药企数智化转型的5个阶段与自测评估 | 药智云知识中心 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/pharma-digital-transformation-trends-2025.html 2026-09-28 knowledge 2025年医药数智化转型趋势展望 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/pharma-ocr-replace-manual-entry.html 2026-09-28 knowledge 医药票据数智化：OCR如何替代手工录入 | 药智云知识中心 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/pharma-outflow-terminal-management-guide.html 2026-09-28 knowledge 处方药外流院外市场运营管理指南 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/pharma-rebate-compliance-risks.html 2026-09-28 knowledge 药企返利管理的合规红线：哪些操作可能踩雷？ | 药智云知识中心 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/pharmacy-display-digital-inspection.html 2026-09-28 knowledge 药店陈列检查数智化：照片留痕如何替代手写台账 | 药智云知识中心 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/pharmacy-rebate-settlement-launch-checklist.html 2026-09-30 knowledge 药企返利对账项目启动前检查清单：先对齐规则、数据与责任 | 药智云知识中心 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/pharmacy-rebate-settlement-optimization.html 2026-09-28 knowledge 药店返利结算优化策略 - 提升渠道效率与合规性 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/pharmacy-visit-standard-process.html 2026-09-28 knowledge 药店终端拜访标准化流程：从计划到执行复盘 | 药智云知识中心 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/rebate-settlement-automation-guide.html 2026-09-28 knowledge 流向返利结算系统｜返利对账慢、核销难：如何把返利结算做成闭环 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/rebate-settlement-why-first-landing-scene.html 2026-09-28 knowledge 商业返利结算，为什么是流向系统最容易落地的应用场景？｜药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/retail-pharmacy-ai-management-guide.html 2026-09-28 knowledge 智店通｜处方药院外市场增长：AI赋能单人管理500+药店 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/rwe-innovative-drug-insurance-negotiation.html 2026-09-28 knowledge 真实世界证据如何助力创新药医保谈判 | 药智云知识中心 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/rwe-rws-introduction-for-pharma.html 2026-09-28 knowledge 真实世界研究入门：药企为什么要做RWS | 药智云知识中心 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/rws-data-collection-challenges.html 2026-09-28 knowledge RWS数据采集的三大难题与解决思路 | 药智云知识中心 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/rx-patient-education-compliance-boundary.html 2026-09-28 knowledge 处方药患者教育的合规边界在哪里？ | 药智云知识中心 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/sfe-performance-first-entry-for-flow-data.html 2026-09-28 knowledge SFE绩效统计，为什么是流向数据进入销售管理的第一入口？｜药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/knowledge/why-pharma-flow-system-fails-to-see-market.html 2026-09-28 knowledge 为什么药品流向系统做了还是看不清市场？ | 药智云行业洞察 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/llms-full.txt 2026-09-29 fact-source llms-full.txt zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/llms.txt 2026-09-29 fact-source llms.txt zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news.html 2026-09-28 webpage 内容中心 - 药智云医药数智化平台 | 行业资讯与知识分享 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/ 2026-09-28 news 动态中心 - 医药数智化行业资讯 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/2026-compliance-flight-inspection.html 2026-09-28 news 2026医保飞检全面升级，药企合规系统（学术会议+防舞弊）迎来黄金建设期 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/2026-pharma-compliance-flight-inspection-guide.html 2026-09-28 news 2026 开年 7 家药企因商贿被通报，你的学术会议证据链准备好了吗？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/academic-event-version-evidence-chain-2026.html 2026-09-28 news 学术活动材料如何形成可复核的版本证据链？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/academic-meeting-risk-depends-on-evidence-chain-closure.html 2026-09-28 news 学术会结束后，真正决定风险高低的是证据链能不能闭环 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/academic-promotion-compliance-shift-left-under-frequent-inspections.html 2026-09-28 news 飞行检查常态化之后，学术推广为什么要更早做合规前置？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/academic-promotion-from-execution-management-to-business-management.html 2026-09-28 news 合规趋严下，学术推广如何从执行管理走向经营管理 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/agent-management-system-launch.html 2026-09-28 news 代理商管理系统助力渠道精细化运营 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/ai-drug-regulation-data-evidence-chain.html 2026-09-28 news “人工智能+药品监管”落地后：药企先补齐哪一条数据证据链？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/ai-drug-regulation-evidence-chain-first.html 2026-09-28 news AI+药品监管之后，药企最先要补的不是模型，而是证据链 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/ai-drug-regulation-pharma-digital-foundation.html 2026-09-28 news 国家药监局“AI+药品监管”落地，药企最该补的是什么？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/ai-flow-platform-3-release.html 2026-09-28 news 药智云AI流向处理平台3.0发布 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/ai-in-pharma-marketing-means-better-coverage-decisions.html 2026-09-28 news AI + 医药营销，真正能落地的不是概念，而是覆盖决策 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/ai-medical-research-rws-evidence-chain-2026.html 2026-09-28 news AI进入医学研究后，药企如何管理RWS证据链？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/ai-meeting-compliance-review-efficiency.html 2026-09-28 news AI如何把45分钟人工审核压缩到8分钟 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/car-t-rare-disease-rws-patient-lifecycle-data-loop.html 2026-09-28 news 从CAR-T到罕见病：研究管理的终点是患者全生命周期数据闭环 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/case-compliance-zero-issue-inspection.html 2026-09-28 news 客户案例：某药企飞检零问题，背后的数智化合规体系 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/case-drug-flow-reduce-70-percent-manual.html 2026-09-28 news 客户案例：某中型药企用流向融合平台减少手工对账 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/case-mms-manage-tens-of-thousands-meetings.html 2026-09-28 news 客户案例：某上市药企用MMS管理全年数万场学术会议 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/case-otc-smart-rebate-60-percent-dispute-reduction.html 2026-09-28 news 客户案例：某OTC企业用智能返利系统减少结算纠纷 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/case-patient-crm-follow-up-rate-92-percent.html 2026-09-28 news 客户案例：某创新药企用患者CRM提升随访完成率至92% - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/case-smart-visit-execution-rate-88-percent.html 2026-09-28 news 客户案例：智店通上线后的拜访执行留痕 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/case/ 2026-09-28 news 客户案例 - 动态中心 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/cde-22-oncology-bepk-subject-selection-evidence-chain.html 2026-09-28 news CDE 2026年第22号通告解读：肿瘤药BE/PK比对研究受试者选择怎么做才合规、可审计？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/compliance-system-certification.html 2026-09-28 news 药智云合规智能审查系统正式发布，AI驱动学术会议全流程合规审查 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/compliance-system-pre-alert-evidence-chain.html 2026-09-28 news 飞检前才补材料，已经来不及了：药企合规要从人工抽查转向系统提醒 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/core-value-of-zhidiantong-store-visit-efficiency-or-sales-closed-loop.html 2026-09-28 news 智店通的核心价值，到底是巡店提效，还是动销闭环 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/corrective-action-closure-after-risk-control.html 2026-09-28 news 风险控制措施后的整改闭环：从暂停销售到复核关闭的五步证据链 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/cso-service-record-evidence-review-fee-verification-loop.html 2026-09-28 news 从服务记录到费用核定：药企如何建立可追溯的 CSO 管理闭环？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/digital-transformation-trends-2025.html 2026-09-28 news 2025医药营销数智化转型趋势报告：AI驱动成为核心竞争力 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/drug-admin-regulations-implementation-mah-compliance-evidence-chain.html 2026-09-28 news 《药品管理法实施条例》5/15生效倒计时：MAH如何用“制度+证据链”把合规落地到可审计？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/drug-pricing-mechanism-innovation-drug-evidence-assets.html 2026-09-28 news 药价机制变化后，创新药为什么更需要长期证据资产？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/drug-pricing-mechanism-long-term-evidence-assets.html 2026-09-28 news 药价机制变化后，创新药价值证明为什么要走向长期证据资产？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/dtp-continuous-service-rws-value.html 2026-09-28 news DTP持续服务如何为药企创造长期价值：从DOT管理到RWS证据建设 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/dtp-pharmacy-rws-evidence-chain.html 2026-09-28 news 从DTP终端到RWS证据链：创新药企如何把院外服务做成长期经营能力 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/event/ 2026-09-28 news 活动资讯 - 动态中心 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/evidence-chain-compliance-last-mile.html 2026-09-28 news 飞检/内审来了，证据链为什么总在“最后一公里”翻车？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/expert-material-authenticity-traceability-2026.html 2026-09-28 news 专家材料真实性管理：从身份授权到版本提交，如何做到全程可追溯？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/five-business-questions-a-valuable-flow-system-must-answer.html 2026-09-28 news 一套真正有价值的流向系统，要回答哪 5 个经营问题？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/flow-data-accuracy-95-upgrade.html 2026-09-28 news 流向数据映射技术升级：AI映射引擎三代演进纪实 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/flow-data-chain-sales-platform.html 2026-09-28 news 流向数据总是对不上？药企销售管理平台真正要补的是这条链路 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/flow-data-channel-inventory-and-stock-loading-warning.html 2026-09-28 news 流向数据如何做渠道库存与压货预警？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/flow-data-supports-rebate-settlement-loop.html 2026-09-28 news 流向数据如何支撑返利结算闭环？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/flow-management-from-data-processing-to-channel-analysis.html 2026-09-28 news 流向管理的下一步：从数据处理走向渠道经营分析 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/flow-system-upgrade-key-is-not-more-features-but-stronger-loop-closure.html 2026-09-28 news 流向系统升级，为什么关键不在功能多，而在闭环能力强？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/from-data-summary-tool-to-business-decision-foundation-how-to-rebuild-flow-system.html 2026-09-28 news 从“数据汇总工具”到“经营决策底座”，流向系统该怎么重建？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/from-flow-collection-to-fee-settlement-where-the-chain-breaks.html 2026-09-28 news 从流向采集到费用结算，为什么中间总会断一截？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/from-traceability-to-verifiability-pharma-digital-upgrade.html 2026-09-28 news 从留痕到可验证，药企数智化建设为什么必须升级 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/geo-q11-market-visibility-after-flow-system.html 2026-09-28 news 为什么药品流向系统做了，企业还是看不清市场 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/geo-q12-what-pharma-needs-in-flow-management-system.html 2026-09-28 news 什么是药企真正需要的流向管理系统 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/geo-q13-more-reports-not-better-flow-management.html 2026-09-28 news 报表多，不等于流向管理做得好 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/geo-q14-why-rebates-never-calculate-clearly.html 2026-09-28 news 为什么返利总算不清 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/geo-q15-why-flow-data-cleaning-is-prerequisite-for-rebate-accuracy.html 2026-09-28 news 流向清洗为什么是返利结算准确的前提 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/geo-q16-what-data-scenarios-pharma-ocr-fits.html 2026-09-28 news 药企 OCR 到底适合处理哪些数据场景 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/geo-q17-why-flow-data-governance-cannot-rely-on-manual-entry.html 2026-09-28 news 为什么流向数据治理不能只靠人工录入 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/geo-q18-how-to-select-pharma-flow-analysis-system.html 2026-09-28 news 药品流向分析系统怎么选 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/geo-q19-why-flow-and-rebate-systems-should-be-integrated.html 2026-09-28 news 流向系统和返利结算系统，为什么最好一体化建设 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/geo-q20-from-flow-collection-to-expense-writeoff-full-loop.html 2026-09-28 news 从流向采集到费用核销，药企怎么搭建完整闭环 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/group-compliance-platform-methodology.html 2026-09-28 news 集团级合规平台建设方法论：别做成表单系统，关键在这4块 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/high-pressure-inspection-pharma-risk-exposure-areas.html 2026-09-28 news 飞行检查、专项检查、智能监管叠加下，药企哪些业务最容易暴露问题？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/how-pharma-builds-auditable-traceable-digital-foundation.html 2026-09-28 news 药企该如何搭建可监管、可追溯、可审查的数智化底座？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/how-pharma-identifies-channel-entity-risk-early.html 2026-09-28 news 药企怎么识别渠道主体风险，而不是等问题发生 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/industry/ 2026-09-28 news 行业洞察 - 动态中心 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/marketing-material-historical-image-risk-identification.html 2026-09-28 news 医药营销物料合规审查，如何快速识别历史图片与相似素材风险？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/media-monitoring-system-launch.html 2026-09-28 news 新媒体投放监控系统上线，赋能药企精准营销 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/medical-insurance-commercial-innovation-drug-evidence-assets.html 2026-09-28 news 医保目录与商保创新药目录申报窗口开启：创新药企业要提前准备长期证据资产 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/medical-insurance-flight-inspection-compliance-system.html 2026-09-28 news 医保飞检风暴升级：药企如何用30分钟构建免检级合规体系？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/medical-insurance-flycheck-rebate-traceability.html 2026-09-28 news 医保飞检扩面提质下的返利结算破局：如何把返利对账/核销做成闭环与分钟级取证？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/medical-insurance-smart-supervision-compliance-evidence-chain.html 2026-09-28 news 医保智能监管“两库”第十批发布：药企合规，不能再只靠事后补证 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/medical-insurance-smart-supervision-process-verifiable-compliance.html 2026-09-28 news 医保智能监管“两库”持续更新：药企合规为什么要从事后补证转向过程可验证？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/medical-insurance-smart-supervision-rules-compliance-pre-alert.html 2026-09-28 news 医保智能监管“两库”第十三批发布：药企合规要从事后补证，走向事前提醒 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/medical-insurance-two-libraries-terminal-compliance-2026.html 2026-09-28 news 医保智能监管“两库”连续更新：药企终端管理进入规则前置时代 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/medical-representative-management-compliance-evidence-chain-2026.html 2026-09-28 news 医药代表管理办法8月施行：药企如何补齐学术推广合规证据链？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/medical-representative-registration-visit-evidence.html 2026-09-28 news 医药代表备案之后，拜访证据如何做到连续可调取？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/medical-service-item-catalog-value-evidence.html 2026-09-28 news 医疗服务项目目录开始制定后：新技术项目如何准备可解释的价值证据 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/medicare-responsibility-evidence-chain-2026.html 2026-09-28 news 医保监管走向“责任到人”：药企如何建立人员、活动、费用与数据证据链 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/medicare-smart-supervision-drug-indication-compliance-2026.html 2026-09-28 news 医保智能监管前移：药企如何从事后补证据转向事前提醒 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/meeting-compliance-image-material-traceability.html 2026-09-28 news 会议图片分批提交，合规系统能识别出来吗？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/mms-v2-auto-approval-release.html 2026-09-28 news MMS会议管理系统V2发布：新增自动化审批引擎，会议立项到结案效率提升60% - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/national-terminal-map-for-pharma-regional-operations.html 2026-09-28 news 药企区域经营，为什么需要一张全国终端经营地图 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/new-drug-regulation-countdown-may-2026.html 2026-09-28 news 5/15新规倒计时｜药品管理法实施条例加严：药企如何构建可审计证据链 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/new-technology-preliminary-approval-value-evidence.html 2026-09-28 news 高水平新技术新产品预立项：医疗创新不能只准备技术说明书 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/nhsa-iit-compliance-redlines.html 2026-09-28 news 医保飞检之下，IIT合规红线在哪里？（从官方案例看科研合作与证据链） - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/npc-cppcc-pharma-digital-priority-reset.html 2026-09-28 news 两会后，药企数智化建设的优先级已经变了：先补合规证据链，再谈增长效率 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/online-drug-sales-risk-process-traceability.html 2026-09-28 news 网络售药风险与过程留痕：从监管信号到企业证据连续性自查 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/otc-brand-coverage-50-percent.html 2026-09-28 news 客户案例：某OTC品牌通过智店通提升终端覆盖 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/outpatient-terminal-management-under-innovation-drug-policy-shift.html 2026-09-28 news 创新药政策变化下，院外终端为什么需要更精细化管理？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/patient-crm-upgrade.html 2026-09-28 news 患者关系管理系统全新升级，助力精准患者服务 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/patient-followup-continuous-evidence-crm-2026.html 2026-09-28 news 患者随访如何从服务记录变成连续证据？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/pharma-compliance-evidence-chain-2026.html 2026-09-28 news 2026医药纠风要点下，药企学术推广证据链怎么补？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/pharma-distributor-management-system-needs-more-than-archives.html 2026-09-28 news 药品代理商管理系统，真正要管的不只是档案 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/pharma-flow-data-governance-rebate-audit-traceability.html 2026-09-28 news 药品流向数据如何支撑返利结算和审计追溯？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/pharma-marketing-entering-all-domain-linkage-era.html 2026-09-28 news 从医院到诊所到药店，医药营销进入全域联动时代 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/pharma-needs-ai-systems-for-operations-and-compliance-not-platform-talk.html 2026-09-28 news 别人都在讲AI平台，药企真正需要的是AI可落地的经营与合规系统 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/pharma-needs-decision-capability-not-just-more-data.html 2026-09-28 news 48万药店、20万诊所背后，药企真正缺的不是数据，而是经营决策能力 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/pharma-procurement-compliance-self-checklist.html 2026-09-28 news 药企招采合规自查清单：从采购记录到费用与流向互证 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/pharma-procurement-data-from-reporting-to-traceability.html 2026-09-28 news 药品采购数据为什么要从“报上去”走向“能回查” - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/pharmacy-terminal-self-check-verifiable-growth.html 2026-09-28 news 药店违规典型案例第三期之后：终端管理要能支持自查自纠，而不只是活动打卡 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/pharmacy-two-ledgers-out-of-hospital-terminal-digitalization.html 2026-09-28 news 药店“两本账”被查之后：院外终端，不能只看销量 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/pharmacy-two-ledgers-terminal-process-verification.html 2026-09-28 news 药店“两本账”被查之后：药企院外终端管理，为什么要从销量导向转向过程可核验？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/prescription-drug-out-of-hospital-channel-compliance-evidence-chain.html 2026-09-28 news 处方药院外渠道合规怎么做？从拜访留痕到动销证据链 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/prescription-drug-outflow-pharmacy-management.html 2026-09-28 news 处方药外流加速，药店单人如何管理 500+ 终端？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/procurement-credit-fee-flow-mutual-verification-2026.html 2026-09-28 news 招采信用约束下，药企如何让费用、票据、流向与业务动作相互验证？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/product/ 2026-09-28 news 产品动态 - 动态中心 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/rebate-traceability-not-just-calculation-speed.html 2026-09-28 news 返利为什么总算不清？不是算得慢，而是过程不可追溯 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/receipt-rebate-trusted-terminal-loop.html 2026-09-28 news 小票返利越做越大，药企最怕的不是没人参与，而是数据不可信 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/regional-carryover-after-academic-activities.html 2026-09-28 news 学术活动之后，区域承接才是真正的胜负手 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/rws-platform-multi-center-data-collaboration.html 2026-09-28 news RWS平台发布：支持多中心研究数据协同采集 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/shenzhen-online-procurement-compliance-evidence-chain.html 2026-09-28 news 深圳线上采购通知之后：药企如何把备案、填报和回查做成证据链 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/smart-territory-planning-based-on-medical-resources.html 2026-09-28 news 智能辖区规划 2.0：按医疗资源做市场配置，而不是按行政区划 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/three-common-mistakes-in-pharma-territory-planning.html 2026-09-28 news 药企辖区划分的 3 个常见误区 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/three-compliance-breakpoints-pharma-fails-first.html 2026-09-28 news 飞检常态化之后，药企今年最容易踩雷的3个合规断点 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/three-product-one-device-ad-review-content-compliance-checklist.html 2026-09-28 news 三品一械广告审查征求意见：药企内容合规自查清单 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/top10-pharma-efficiency-40-percent.html 2026-09-28 news 客户案例：某大型药企通过药智云平台实现营销管理效率显著提升 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/trace-code-data-governance.html 2026-09-28 news 追溯基础设施建成后，药企还要补齐哪几条数据链？从上传合规到渠道穿透 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/w30-pharmacy-precheck-execution-loop.html 2026-09-28 news 零售药店事前提醒接入率82%后的终端闭环 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/w30-specialty-alliance-rws.html 2026-09-28 news 专病联盟患者管理与多中心RWS复制 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/w30-tcm-indication-compliance-loop.html 2026-09-28 news 第二十批“两库”与中成药限适应症合规闭环 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/what-kind-of-distributor-management-system-supports-growth-and-risk-control.html 2026-09-28 news 什么样的代理商管理系统，才算真正能支撑业务增长与风控 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/what-kind-of-rws-platform-is-truly-fit-for-pharma.html 2026-09-28 news 什么样的 RWS 平台，才算真正适合药企使用 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/what-pharma-gains-after-connecting-four-resource-layers.html 2026-09-28 news 四类资源打通后，药企能获得什么 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/which-pharma-companies-feel-ai-regulation-pressure-first.html 2026-09-28 news 哪些药企会最先感受到 AI 监管带来的压力？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/why-complex-channel-recruitment-needs-systematic-management.html 2026-09-28 news 为什么招商渠道越复杂，越需要系统化管理 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/why-cso-management-cannot-only-look-at-partner-lists.html 2026-09-28 news 为什么经销商 / CSO 管理，不能只看合作名单 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/why-distributor-alias-matching-is-a-hidden-channel-problem.html 2026-09-28 news 为什么代理商异名匹配，是渠道管理里的隐藏难题 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/why-distributor-cooperation-needs-full-process-traceability.html 2026-09-28 news 为什么代理商合作关系，必须做到全过程留痕 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/why-distributor-qualification-contract-performance-must-be-connected.html 2026-09-28 news 代理商资质、合同、业绩，为什么必须打通看 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/why-distributor-rebates-and-channel-management-must-work-together.html 2026-09-28 news 为什么代理商返利和渠道管理，不能各管各的 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/why-finishing-regional-sales-targets-still-does-not-reassure-management.html 2026-09-28 news 区域销售看起来完成了任务，为什么企业还是不放心？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/why-iit-and-post-marketing-studies-fear-follow-up-breaks-most.html 2026-09-28 news 为什么 IIT / 上市后研究，最怕患者随访断链 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/why-innovative-pharma-needs-patient-management-and-rws-together.html 2026-09-28 news 创新药进入商业化深水区后，为什么患者管理和真实世界证据要一起做 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/why-pharma-distribution-systems-feel-heavier-after-upgrades.html 2026-09-28 news 不是数据更多了，而是管理更失控了：药企流向系统为什么越升级越累 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/why-pharma-distributor-management-can-no-longer-rely-on-excel.html 2026-09-28 news 为什么药企代理商管理越来越不能靠 Excel - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/why-pharma-needs-to-rebuild-cso-service-management-2026.html 2026-09-28 news CSO合作进入精细化管理阶段，药企为什么要重建推广服务管理标准？ - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/why-pharmacy-terminal-management-can-no-longer-rely-on-spreadsheets-and-group-chats.html 2026-09-28 news 为什么药店终端管理不能再靠表格和群消息 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/why-prescription-drugs-in-out-of-hospital-markets-need-terminal-digitalization.html 2026-09-28 news 处方药做院外市场，为什么越来越需要终端数智化 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/why-rws-can-no-longer-run-on-scattered-spreadsheets.html 2026-09-28 news 为什么真实世界研究越来越不能靠分散表格推进 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/why-store-clerk-crowdsourcing-can-become-a-new-driver-of-terminal-growth.html 2026-09-28 news 为什么店员众包任务，能成为终端增长的新抓手 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/why-terminal-receipt-data-is-becoming-the-key-feedback-entry-for-out-of-hospital-sales.html 2026-09-28 news 为什么终端小票数据，正在变成院外动销最重要的反馈入口 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/news/zhidiantong-smart-terminal-platform-upgrade.html 2026-09-28 news 智店通，正在从药店工具升级为连接药店与第三终端的智能终端运营平台 - 药智云资讯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/products.html 2026-09-28 product 产品中心 - 药智云 | 执行记录·费用追溯·合规审计 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/products/agent-management.html 2026-09-28 product 药企代理商与经销商管理系统｜产品授权、渠道协同与流向管理 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/products/compliance-system.html 2026-09-28 product 药企合规审计系统 - 金税四期AI发票智能抓取与预警 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/products/flow-data-system.html 2026-09-28 product 药品流向数据清洗系统 - AI智能异名匹配 | 商业公司数据标准化 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/products/incentive-rewards.html 2026-09-28 product OTC小票晒单与终端动销激励系统｜小票核验、奖励与活动对账 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/products/kol-management.html 2026-09-28 product 讲者管理与学术推广系统 - 药智云 | 杭州药智云科技有限公司 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/products/meeting-management.html 2026-09-28 product 学术会议管理系统MMS - 会议全生命周期数智化管理 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/products/patient-management.html 2026-09-28 product 患者CRM管理系统 - 罕见病全生命周期智能管理 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/products/pharma-flow-platform.html 2026-09-28 product 药智OCR数据处理平台 - 智能票据识别系统 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/products/pharma-visit.html 2026-09-28 product 智店通 - 处方药院外渠道合规动销与证据链管理系统 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/products/rebate-system.html 2026-09-28 product 智能返利结算系统 - 药智云 | 政策匹配、核算、对账与追溯 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/products/rwe-platform.html 2026-09-28 product 药企RWS真实世界研究平台 - EDC电子数据采集 | CDISC标准 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/products/territory-planning.html 2026-09-28 product 智能辖区规划系统 - AI驱动销售辖区科学分配 | 数学优化+空间分析 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/products/zhifutong.html 2026-09-28 product 智服通 - 医药CSO推广服务行为管理与服务费核定 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/proposals.html 2026-09-28 webpage 解决方案案例 - 药智云医药数智化解决方案展示 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/solutions.html 2026-09-29 solution 药企营销执行与合规解决方案 | 流向、返利、会议、CSO管理 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/solutions/drug-flow-data-processing.html 2026-09-29 solution 药品流向管理系统：数据清洗、OCR 与返利对账 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/solutions/meeting-compliance-review.html 2026-09-28 solution 学术会议合规审查系统方案 - AI智能检测 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/solutions/new-drug-launch-marketing.html 2026-09-28 solution 新药上市营销怎么做？数智化营销解决方案 - 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/solutions/pharma-channel-partner-management.html 2026-09-21 solution 药企渠道合作伙伴管理方案｜代理商、医药商业、零售与CSO管理 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/solutions/pharma-compliance-management.html 2026-09-28 solution 医药企业合规管理怎么做？AI智能合规系统 - 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/solutions/pharmacy-rebate-settlement.html 2026-09-30 solution 药店返利怎么结算？智能返利结算系统 - 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/solutions/rare-disease-management.html 2026-09-28 solution 罕见病数智化管理解决方案 - AI智能患者管理系统 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/solutions/rwe-research-platform.html 2026-09-28 solution 真实世界研究数据平台解决方案 - RWE数据管理 | 药智云 zh-CN pharmaceutical-marketing https://www.yaozhi.cloud/solutions/zhidian-incentive.html 2026-09-28 solution 智店激励通｜连锁门店动销与导购激励管理系统 | 药智云 zh-CN pharmaceutical-marketing